The economic burden of malaria inpatients and its determinants during China's elimination stage
Malaria burden is still worrisome, while empirical evidence from malaria-eliminated countries including China may provide inspiration for the world. This study aimed to investigate China's malaria hospitalization costs and explore its determinants. Stratified multistage sampling across provinci...
Gespeichert in:
Veröffentlicht in: | Frontiers in public health 2022-10, Vol.10, p.994529-994529 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Malaria burden is still worrisome, while empirical evidence from malaria-eliminated countries including China may provide inspiration for the world.
This study aimed to investigate China's malaria hospitalization costs and explore its determinants.
Stratified multistage sampling across provincial, municipal, and county hospitals was conducted in 2017. All the malaria medical records were retrieved from 2014 to 2016 in 70 hospitals. Parametric and non-parametric methods were employed to estimate hospitalization costs, and the non-parametric bootstrap was used to compare hospitalization costs among sample areas and assessed the uncertainty of its differences. Quantile regressions were conducted to identify the determinants of hospitalization costs.
The median hospitalization costs of 1633 malaria inpatients were 628 USD. Medication and laboratory tests accounted for over 70% of total expenditure. The median reimbursement rate was 41.87%, and this number was even lower in higher-level hospitals ( |
---|---|
ISSN: | 2296-2565 2296-2565 |
DOI: | 10.3389/fpubh.2022.994529 |